Induction of the death-promoting gene bax-α sensitizes cultures breast-cancer cells to drug-induced apoptosis

International Journal of Cancer

Volumn 67, Issue 1, 1996, Pages 138-141

  Wagener, Christian ^a   Bargou, Ralf C ^a,b   Daniel, Peter T ^a,b   Bommert, Kurt ^a   Mapara, Markus Y ^a,b   Royer, Hans D ^a   Dörren, Bernd ^a,b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; EPIRUBICIN; FEMALE; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENES; TUMOR CELLS, CULTURED;

EID: 0030062205     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960703)67:1<138::AID-IJC22>3.0.CO;2-9     Document Type: Article

References (24)

1. APTE, S.S., MATTEI, M.G. and OLSEN, B.R., Mapping of the human bax gene to chromosome 19ql3.3-ql3.4 and isolation of a novel alternatively spliced transcript, bax-delta. Genomics, 26, 592-594 (1995).
2. BARGOU, R.C., DANIEL, P.T., MAPARA, M.Y., BOMMERT, K., WAGENER, C., KALLINICH, B., ROYER, H.D. and DÖRKEN, B., Expression of the bcl-2 gene family in normal and in malignant breast tissue: low bax-a expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer, 60, 854-859 (1995).
3. BOISE, L.H., GONZALEZ-GARCIA, M., POSTEMA, C.E., DING, L., LINDSTEN, T., TURKA, L.A., MAO, X., NUNEZ, G. and THOMPSON, C.B., bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608 (1993).
4. CHIOU, S.K., RAO, L. and WHITE, E., bcl-2 blocks p53-dependent apoptosis. Mol. cell. Biol., 14, 2556-2563 (1994).
5. DOLE, M., NUNEZ, G., MERCHANT, A.K., MAYBAUM, J., RODE, C.K., BLOCH, C.A. and CASTLE, V.P., bcl-2 protein inhibits chemotherapyinduced apoptosis in neuroblastoma. Cancer Res., 54, 3253-3259 (1994).
6. ELLIS, R.E., YUAN, J.Y. and HORVITZ, H.R., Mechanisms and functions of cell death. Ann. Rev. Cell Biol., 7, 663-698 (1991).
7. GOSSEN, M. and BUJARD, H., Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. nat. Acad. Sci. (Wash.), 89, 5547-5551 (1992).
8. KAMESAKI, S., KAMESAKI, H., JORGENSON, T.J., TANIZAWA, A., POMMIER, Y. and COSSMAN, J., bcl-2 protein inhibits etoposide-induced apoptosis through its effect on events subsequent to topoisomerase-Hinduced strand breaks and their repair. Cancer Res., 53, 4251-4256 (1993).
9. KRAJEWSKI, S., BLOMQVIST, C., FRANSSILA, K., KRAJEWSKI, M., WASENIUS, V.-M., NISKANEN, E., NORDLING, S. and REED, J.C., Reduced expression of pro-apoptotic gene bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res., 55, 4471-4478 (1995).
10. LOWE, S.W., RULEY, H.E., JACKS, T. and HOUSMAN, D.E., p53dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell, 74, 957-967 (1993).
11. MIYASHITA, T., HARIGAI, M., HANADA, M. and REED, J.C., Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res., 12, 3133-3135 (1994a).
12. MIYASHITA, T., KRAJEWSKI, S., KRAJEWSKI, M., WANG, H.G., LIN, H.K., LIEBERMANN, D.A., HOFFMANN, B. and REED, J.C., Tumorsuppressor p53 is a regulator of bcl-2- and ear-gene expression in vitro and in vivo. Oncogene, 9, 1799-1805 (1994b).
13. MIYASHITA, T. and REED, J., Tumor-suppressor p53 is direct transcriptional activator of the human box gene. Cell, 80, 293-299 (1995).
14. NlCOLETTI, I., MlGLIORATI, G., PAGLIACCI, M.C., GRIGNANI, F. and RICCARDI, C., A rapid and simple method for measuring thymocyte apoptosis by propidium-iodide staining and flow cytometry. J. immunol Methods, 139, 271-279 (1991).
15. OLTVAI, Z.N., MILLIMAN, C.L. and KORSMEYER, S.J., bcl-2 heterodimerizes in vivo with a conserved homolog, box, that accelerates programmed cell death. Cell, 74, 609-619 (1993).
16. RITTER, K., STÖPFER, H., PAWLITA, M. and SCZAKIEL, G., Versatile eucaryotic vectors for strong and constitutive transient and stable gene expression. Methods mol. cell. Biol., 2, 176-181 (1991).
17. SHAW, P., BOVERY, R., TARDY, S., SAHLI, R., SORDAT, B. and COSTA, J., Induction of apoptosis by wild-type p53 in a human colon-tumorderived cell line. Proc. nat. Acad. Sci. (Wash.), 89, 5214-5218 (1992).
18. SUMANTRAN, V.N., EALOVEGA, M.W., NUNEZ, G., CLARKE, M.F. and WICHA, M.S., Over-expression of bcl-x5 sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res., 55, 2507-2510 (1995).
19. TSUJIMOTO, Y. and CROCE, C.M., Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.Proc. nat. Acad. Sci. (Wash.), 83, 5214-5218 (1986).
20. TSUJIMOTO, Y., FINGER, L.R., YUNIS, J., NOWELL, P.C. and CROCE, C.M., Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science, 226, I097-1099 (1984).
21. TSUJIMOTO, Y., GORHAM, J., COSSMAN, J., JAFFE, E. and CROCE, C.M., The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science, 299, 1390-1393 (1985).
22. TSUJIMOTO, Y., IKEGAKI, N. and CROCE, C.M., Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene, 2, 3-7 (1987).
23. VAUX, D.L., CORY, S. and ADAMS, J.M., bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335, 440-442 (1988).
24. YONISH-ROUACH, E., RESNITZKY, D., LOTEM, J., SACHS, L., KIMCHI, A. and OREN, M., Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352, 345-347 (1991).